Activation of TRPML channels induces Ca2+ release [30], thus we performed a dose response assay to evaluate [Ca2+]i levels in glioma cells stimulated with a TRPML-1 specific agonist. The gene discussed is MCOLN1; the disease is central nervous system cancer.